Request Demo
Last update 08 May 2025
Kharazmi Pharmaceutical Co.
Last update 08 May 2025
Overview
Related
IRCT20200105046010N97
In-vivo Bioequivalence Study of Empagliflozin/Linagliptin 25/5 mg Kharazmi Pharma Co Tablets of The Test Drug in Compared with The Reference Drug (GLYXAMBI® Tab 25/5 mg. Beohringer Ingelheim Germany) In Healthy Volunteers
IRCT20200105046010N101
In-vivo Bioequivalence Study of Linagliptin/Metformin 2.5/1000 mg FC. Tablets of The Test Drug (Kharazmi Pharma, Iran) in Compared with The Reference Drug (Jentadueto® 2.5/1000 mg, Boehringer Ingelheim, Germany) in fasting condition in healthy volunteers
IRCT20200105046010N95
In-vivo Bioequivalence Study of Empagliflozin/Metformin 5/500 mg FC. Tablets of The Test Drug (JARINOMET® 5/500 mg Tab. Kharazmi Pharma, Iran) in Compared with The Reference Drug (SYNJARDI® 5/500 mg. Boehringer Ingelheim Germany) In Iranian Healthy Volunteers
100 Clinical Results associated with Kharazmi Pharmaceutical Co.
Login to view more data
Login to view more data
100 Deals associated with Kharazmi Pharmaceutical Co.
Login to view more data
100 Translational Medicine associated with Kharazmi Pharmaceutical Co.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 09 Jul 2025
No data posted
Login to keep update
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free